-
- Hayasaka Shinichi
- 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
- Takada Minoru
- 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
- Shinohara Tsutomu
- 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
- Imamura Sumitaka
- 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
- Takifuji Nobuhide
- 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
- Kudoh Shinzou
- 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
- Matsui Kaoru
- 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
- Kusunoki Yoko
- 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
- Masuda Noriyuki
- 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
- Negoro Shunichi
- 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
-
- Fukuoka Masahiro
- 2nd Department of Internal Medicine, Osaka Prefectural Habikino Hospital
Bibliographic Information
- Other Title
-
- 肺癌におけるＣＡ‐５０，ＳＬＸ， ＳＴ‐４３９の検討
Search this article
Description
Serum levels of CA-50, SLX and ST-439 were measured in 213 patients with lung cancer (92 adenocarcinomas, 63 squamous cell carcinomas, 37 small cell carcinomas and 21 large cell carcinomas) and 87 patients with benign lung disease.<br>The overall positive rates in patients with lung cancer were 12.8% for CA-50, 29.7% for SLX and 25.3% for ST-439. The positive rates for CA-50, SLX and ST-439 in adenocarcinoma patients were 22.8%, 42.4% and 38.0%, respectively.<br>Of the patients with benign lung disease, 4.8% were false positive for CA-50, 15.3% for SLX and 3.6% for ST-439.<br>In the patients with adenocarcinoma of the lung, the combination assay of CEA and ST-439 had a highly accurate rate (61.9%).
Journal
-
- The Japanese journal of thoracic diseases
-
The Japanese journal of thoracic diseases 29 (7), 802-807, 1991
The Japanese Respiratory Society
